Arcadia Biosciences, Inc. (NASDAQ:RKDA) was held by 2 institutional investors that filed 13F reports for the quarter ended June 30, 2026.
These investors held 0.03% of Arcadia Biosciences' outstanding shares at the end of Q2 2026, down from 0.05% in Q1 2026.
Total holdings of Arcadia Biosciences shares were unchanged compared with Q1 2026.
Altogether, institutional holders owned 1K RKDA shares at the end of Q2 2026, unchanged from the prior quarter.
Bullock Wealth Management Group held the largest position in RKDA at 1K shares as of June 30, 2026, or 0.03% of shares outstanding.
Per Business Quant, the top 2 investors in RKDA for the quarter ended June 30, 2026 were Bullock Wealth Management Group (1K shares) and Harbour Investments, Inc. (1 share).